Atara Biotherapeutics: 3Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $58.4 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.29.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.18 per share.
Atara Biotherapeutics shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.